"Designing Growth Strategies is in our DNA"

U.S. Intrathecal Drugs Market Size, Share & Industry Analysis, By Drug (Morphine, Baclofen, Ziconotide, Bupivacaine, Hydromorphone, Clonidine, and Others), By Application (Pain Management and Spasticity), By Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2025-2032

Last Updated: December 08, 2025 | Format: PDF | Report ID: FBI111773

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Approved Drugs for Intrathecal Use & Off-label Use of Drugs through Intrathecal Pumps
    2. Recommended Dose: Drugs for Intrathecal Pumps
    3. Impact of COVID-19 on the U.S. Intrathecal Pumps Market
  5. U.S. Intrathecal Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug 
      1. Morphine
      2. Baclofen
      3. Ziconotide
      4. Bupivacaine
      5. Hydromorphone
      6. Clonidine
      7. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Pain Management
      2. Spasticity
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Hikma Pharmaceuticals PLC
      2. Piramal Critical Care
      3. Baxter
      4. Novartis AG
      5. TerSera Therapeutics LLC
      6. Mylan N.V.
      7. Pfizer Inc.
  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Approved Drugs for Intrathecal Use & Off-label Use of Drugs through Intrathecal Pumps
    2. Recommended Dose: Drugs for Intrathecal Pumps
    3. Impact of COVID-19 on the U.S. Intrathecal Pumps Market
  5. U.S. Intrathecal Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug 
      1. Morphine
      2. Baclofen
      3. Ziconotide
      4. Bupivacaine
      5. Hydromorphone
      6. Clonidine
      7. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Pain Management
      2. Spasticity
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Hikma Pharmaceuticals PLC
      2. Piramal Critical Care
      3. Baxter
      4. Novartis AG
      5. TerSera Therapeutics LLC
      6. Mylan N.V.
      7. Pfizer Inc.
Read Less

Figure 1:  U.S. Intrathecal Drugs Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2:  U.S. Intrathecal Drugs Market Value Share (%), by Drug, 2024 & 2032

Figure 3:  U.S. Intrathecal Drugs Market Value Share (%), by Application, 2024 & 2032

Figure 4:  U.S. Intrathecal Drugs Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 5:  U.S. Intrathecal Drugs Market Share (%), By Company, 2024

Table 1:  U.S. Intrathecal Drugs Market Revenue (USD billion) Forecast, by Drug, 2019–2032

Table 2:  U.S. Intrathecal Drugs Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 3:  U.S. Intrathecal Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

U.S. Intrathecal Drugs Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 85
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann